Search Results

Filter
  • 1-10 of  2,183 results for ""Drug development""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

INTRODUCTION: Public Sector and Non-Profit Contributions to Drug Development - Historical Scope, Opportunities, and Challenges.

Subjects: Drug Costs* ; Organizations, Nonprofit* ; Private Sector*

  • Source: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 6-9.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

A brief history of antidepressant drug development: from tricyclics to beyond ketamine.

  • Authors : Pereira VS; 1Translational Neuropsychiatry Unit,Department of Clinical Medicine,Aarhus University,Risskov,Denmark.; Hiroaki-Sato VA

Subjects: Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/*pharmacology ; Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/Antidepressive Agents, Tricyclic/*therapeutic use ; Drug Development/Drug Development/Drug Development/*history

  • Source: Acta neuropsychiatrica [Acta Neuropsychiatr] 2018 Dec; Vol. 30 (6), pp. 307-322. Date of Electronic Publication: 2018 Feb 01.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9612501 Publication Model: Print-Electronic

Record details

×
Academic Journal

Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective.

  • Authors : Hillock NT; School of Public Health, University of Adelaide, Adelaide, SA5000, Australia.; Merlin TL

Subjects: Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*economics ; Anti-Infective Agents/Anti-Infective Agents/Anti-Infective Agents/*therapeutic use ; Drug Development/Drug Development/Drug Development/*organization & administration

  • Source: International journal of technology assessment in health care [Int J Technol Assess Health Care] 2020 Nov 03; Vol. 37, pp. e28. Date of Electronic Publication: 2020 Nov 03.Publisher: Cambridge University Press Country of Publication: England NLM ID: 8508113 Publication Model: Electronic Cited

Record details

×
Academic Journal

New therapeutic patents used for the treatment of leprosy: a review.

Subjects: Drug Development* ; Patents as Topic*; Leprosy/Leprosy/Leprosy/*drug therapy

  • Source: Epidemiology and infection [Epidemiol Infect] 2018 Oct; Vol. 146 (14), pp. 1746-1749. Date of Electronic Publication: 2018 Aug 07.Publisher: Cambridge University Press Country of Publication: England NLM ID: 8703737 Publication Model: Print-Electronic

Record details

×
Academic Journal

Realizing Public Rights Through Government Patent Use.

Subjects: Biomedical Research/Biomedical Research/Biomedical Research/*economics ; Drug Development/Drug Development/Drug Development/*economics ; Drugs, Generic/Drugs, Generic/Drugs, Generic/*economics

  • Source: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 34-38.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:

Record details

×
Editorial & Opinion

Letter From The Editor.

Subjects: Periodicals as Topic* ; Publishing*; Drug Development/Drug Development/Drug Development/*economics

  • Source: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 1.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward.

Subjects: Biomedical Research*; COVID-19/COVID-19/COVID-19/*prevention & control ; COVID-19 Vaccines/COVID-19 Vaccines/COVID-19 Vaccines/*supply & distribution

  • Source: Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees [Camb Q Healthc Ethics] 2021 Jan; Vol. 30 (1), pp. 59-68. Date of Electronic Publisher: Cambridge University Press Country of Publication: United States NLM ID: 9208482 Publication Model: Print-Electronic

Record details

×
Academic Journal

The Government and Pharmaceutical Innovation: Looking Back and Looking Ahead.

Subjects: Financing, Government* ; Patents as Topic*; Drug Development/Drug Development/Drug Development/*economics

  • Source: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2021; Vol. 49 (1), pp. 10-18.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Antibiotic Pipeline Coordinators.

  • Authors : Baraldi E; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access.; Lindahl O

Subjects: Anti-Bacterial Agents* ; Drug Discovery*; Drug Development/Drug Development/Drug Development/*organization & administration

  • Source: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 25-31.Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  2,183 results for ""Drug development""